Literature DB >> 32289590

The emergence of innovative cannabis distribution projects in the downtown eastside of Vancouver, Canada.

Jenna Valleriani1, Rebecca Haines-Saah2, Rielle Capler1, Ricky Bluthenthal3, M Eugenia Socias1, M J Milloy1, Thomas Kerr1, Ryan McNeil4.   

Abstract

The ongoing overdose crisis in the United States and Canada has highlighted the urgent need for innovative interventions to reduce drug-related harms. This, in turn, has led to increased interest in the potential of cannabis as a harm reduction strategy. While Canada has recently legalized cannabis, meaningful barriers to accessing legal cannabis remain for people who use drugs (PWUD) from marginalized communities. In the Downtown Eastside of Vancouver, Canada, innovative, grassroots cannabis distribution programs that dispense cannabis and cannabis products from unregulated sources to PWUD for free have recently emerged. In this study, we draw upon 23 in-depth qualitative interviews and ethnographic fieldwork with PWUD who access these programs. We found that these distribution programs play an important function in bridging access to cannabis for PWUD in a structurally disadvantaged neighborhood and do so by implementing few restrictions on who can access, providing a variety of cannabis products that would otherwise be inaccessible, and distributing cannabis at no cost. In addition, many people reported the program spaces provided an avenue to socialize and connect. Most of our participants reported that legal cannabis was inaccessible both through the legal medical and non-medical systems. Considering Canadian governments have made important regulatory changes in regards to cannabis, understanding emerging patterns and the structural barriers to accessing legal cannabis will be critical to maximizing the potential uses of cannabis as a harm reduction tool and ensuring equitable access to structurally disadvantaged populations. Examining the impact of cannabis use on PWUD and ensuring these groups have access to cannabis is an important component in determining whether cannabis deregulation reduces drug-related harms.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cannabis; Harm reduction; Qualitative research

Year:  2020        PMID: 32289590      PMCID: PMC7308205          DOI: 10.1016/j.drugpo.2020.102737

Source DB:  PubMed          Journal:  Int J Drug Policy        ISSN: 0955-3959


  58 in total

1.  The impact of a police presence on access to needle exchange programs.

Authors:  Evan Wood; Thomas Kerr; Will Small; Jim Jones; Martin T Schechter; Mark W Tyndall
Journal:  J Acquir Immune Defic Syndr       Date:  2003-09-01       Impact factor: 3.731

Review 2.  Illicit drug use and harms, and related interventions and policy in Canada: A narrative review of select key indicators and developments since 2000.

Authors:  Benedikt Fischer; Yoko Murphy; Katherine Rudzinski; Donald MacPherson
Journal:  Int J Drug Policy       Date:  2015-08-14

3.  A description of a peer-run supervised injection site for injection drug users.

Authors:  Thomas Kerr; Megan Oleson; Mark W Tyndall; Julio Montaner; Evan Wood
Journal:  J Urban Health       Date:  2005-05-04       Impact factor: 3.671

4.  Medical marijuana users in substance abuse treatment.

Authors:  Ronald Swartz
Journal:  Harm Reduct J       Date:  2010-03-05

5.  "We need somewhere to smoke crack": An ethnographic study of an unsanctioned safer smoking room in Vancouver, Canada.

Authors:  Ryan McNeil; Thomas Kerr; Hugh Lampkin; Will Small
Journal:  Int J Drug Policy       Date:  2015-01-19

6.  "People knew they could come here to get help": an ethnographic study of assisted injection practices at a peer-run 'unsanctioned' supervised drug consumption room in a Canadian setting.

Authors:  Ryan McNeil; Will Small; Hugh Lampkin; Kate Shannon; Thomas Kerr
Journal:  AIDS Behav       Date:  2014-03

7.  Recent Increases in Cocaine-Related Overdose Deaths and the Role of Opioids.

Authors:  Christopher McCall Jones; Grant T Baldwin; Wilson M Compton
Journal:  Am J Public Health       Date:  2017-03       Impact factor: 9.308

8.  Cannabis for therapeutic purposes: patient characteristics, access, and reasons for use.

Authors:  Zach Walsh; Robert Callaway; Lynne Belle-Isle; Rielle Capler; Robert Kay; Philippe Lucas; Susan Holtzman
Journal:  Int J Drug Policy       Date:  2013-09-09

Review 9.  Pharmacotherapy of methamphetamine addiction: an update.

Authors:  Ahmed Elkashef; Frank Vocci; Glen Hanson; Jason White; Wendy Wickes; Jari Tiihonen
Journal:  Subst Abus       Date:  2008       Impact factor: 3.716

10.  Substituting cannabis for prescription drugs, alcohol and other substances among medical cannabis patients: The impact of contextual factors.

Authors:  Philippe Lucas; Zach Walsh; Kim Crosby; Robert Callaway; Lynne Belle-Isle; Robert Kay; Rielle Capler; Susan Holtzman
Journal:  Drug Alcohol Rev       Date:  2015-09-14
View more
  5 in total

1.  The role of cannabis in pain management among people living with HIV who use drugs: A qualitative study.

Authors:  Koharu Loulou Chayama; Jenna Valleriani; Cara Ng; Rebecca Haines-Saah; Rielle Capler; M-J Milloy; Will Small; Ryan McNeil
Journal:  Drug Alcohol Rev       Date:  2021-04-11

2.  Factors associated with health-related cannabis use intentions among a community sample of people who inject drugs in Los Angeles and San Francisco, CA 2016 to 2018.

Authors:  Rachel Carmen Ceasar; Alex H Kral; Kelsey Simpson; Lynn Wenger; Jesse L Goldshear; Ricky N Bluthenthal
Journal:  Drug Alcohol Depend       Date:  2020-11-23       Impact factor: 4.492

3.  "If I knew I could get that every hour instead of alcohol, I would take the cannabis": need and feasibility of cannabis substitution implementation in Canadian managed alcohol programs.

Authors:  Bernie Pauly; Meaghan Brown; Clifton Chow; Ashley Wettlaufer; Brittany Graham; Karen Urbanoski; Russell Callaghan; Cindy Rose; Michelle Jordan; Tim Stockwell; Gerald Thomas; Christy Sutherland
Journal:  Harm Reduct J       Date:  2021-06-23

4.  The impact of non-medical cannabis legalization and other exposures on retention in longitudinal cannabis research: a survival analysis of a prospective study of Canadian medical cannabis patients.

Authors:  Philippe Lucas; Susan Boyd; M-J Milloy; Zach Walsh
Journal:  J Cannabis Res       Date:  2021-07-28

5.  "It's Helped Me a Lot, Just Like to Stay Alive": a Qualitative Analysis of Outcomes of a Novel Hydromorphone Tablet Distribution Program in Vancouver, Canada.

Authors:  Andrew Ivsins; Jade Boyd; Samara Mayer; Alexandra Collins; Christy Sutherland; Thomas Kerr; Ryan McNeil
Journal:  J Urban Health       Date:  2020-10-28       Impact factor: 3.671

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.